| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 4,917,749 | $2,950,649 | $0.6000 | 13 Jun 2023 | Shares held through GD Holdings and Lombard International Assurance SA |
| Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 61,256 | $36,754 | $0.6000 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923073232-gaston-dreyfus-remi-2023-06-13 | Bionik Laboratories Corp. | 13 Jun 2023 | 1 | +$1,861,727 | 4 | Director, 10%+ Owner | 21 Jun 2023, 10:59 |
| /report/000110465923073229-gaston-dreyfus-remi-2023-06-09 | Bionik Laboratories Corp. | 09 Jun 2023 | 1 | +$108,333 | 4 | Director, 10%+ Owner | 21 Jun 2023, 10:57 |
| /report/000110465922073083-gaston-dreyfus-remi-2022-03-31 | Bionik Laboratories Corp. | 31 Mar 2022 | 1 | +$739,926 | 4 | Director, 10%+ Owner | 21 Jun 2022, 17:47 |
| /report/000110465921149127-gaston-dreyfus-remi-2021-07-15 | Bionik Laboratories Corp. | 15 Jul 2021 | 4 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:32 |
| /report/000110465921149126-gaston-dreyfus-remi-2021-03-29 | Bionik Laboratories Corp. | 29 Mar 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:31 |
| /report/000110465921149123-gaston-dreyfus-remi-2021-03-26 | Bionik Laboratories Corp. | 26 Mar 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:30 |